AMBER HAMPTON: Open Payments
NPI 1639563489 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 67 payments from 17 companies in 2025. Trend: 2023 $994 · 2024 $1,536 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $313 |
| Alnylam Pharmaceuticals Inc. | 8 | $166 |
| CVRx, Inc. | 13 | $142 |
| AstraZeneca Pharmaceuticals LP | 5 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $97 |
| Merck Sharp & Dohme LLC | 5 | $92 |
| PFIZER INC. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Invivyd Inc | 3 | $79 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $58 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, AMVUTTRA, Barostim Neo System, JARDIANCE, VYNDAQEL, Kerendia, PEMGARDA, VERQUVO.
Industry payments across GA — which companies pay providers there.
